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Release  of histamine  from  sensitized  rabbit  blood  cells  was  first  clearly 
demonstrated in  1966 by Barbaro and Zvaifler (1). Later analysis of this phe- 
nomenon revealed the sequential interaction of antigen with blood basophils (2- 
4),  which had  been  sensitized with  IgE  antibody  (4),  followed by release of 
histamine from blood platelets. Histamine is also liberated from the basophils, 
but in the blood of the rabbit, both histamine and serotonin are found primarily 
(5) in the dense granules of the platelets. We earlier showed that the effect on 
the platelets  was  mediated by  a  soluble  factor released from the  sensitized 
leukocytes (6,  7),  a  factor later termed platelet-activating factor or PAF 1 (4). 
PAF is a low molecular weight material which binds to albumin (4, 8) and has 
recently been shown to be phospholipid in nature (9,  10). In addition, we have 
also described a platelet-activating factor (PAFL) which is liberated from sensi- 
tized chopped rabbit lung fragments upon incubation with specific antigen (11). 
This probably derives from the mast cells and was shown to be different (though 
it is similar in  action) to PAFB from circulating basophils.  Demonstration of 
PAF release in man (4, 12) and rats (10) dispells the rabbits' possible uniqueness 
in possessing this material. 
The in vivo pathologic significance of this system was indicated by its demon- 
strated involvement in the increased vascular permeability in acute experimen- 
tal  immune  complex  disease  resulting  in  the  deposition  of the  circulating 
complexes in vessel walls (13). The deposited complexes then initiate the inju- 
rious process (14). Involvement in other pathologic events may also be indicated 
or  surmised,  e.g.  anaphylactic  shock  (15),  or the  Arthus  reaction  (16). The 
physiologic  role  of this  process  in  amplification  of an  antigen-IgE-basophil 
interaction  is  as  yet unclear  and  must  await  a  clear  understanding  of the 
physiologic functions of the IgE system itself. 
PAF has been shown to induce aggregation of platelets (4, 7) and secretion of 
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their content of histamine and serotonin (7). The release ofvasoactive amines is 
not cytotoxic  (7),  requires platelet energy metabolism and environmental  cal- 
cium,  and is an example of a  secretory reaction similar to that observed in a 
wide variety of cells (17). The importance of the PAF-induced secretion as an in 
vivo mediation process, as a clearly demonstrated and studied example of cell 
cooperation, as an effect of a unique platelet activator, and as a means to study 
the secretory processes of platelets have prompted the studies reported herein. 
These  comprise  a  characterization  of the  secretion  induced  by  PAFB  and  a 
demonstration  of the  unique  features  of this  process,  namely  the  essential 
interplay  between  activation  and  desensitization  which  serves  to  limit  and 
control the secretory event. 
Materials and Methods 
Animals.  New Zealand white rabbits of both sexes weighing from 2.5 to 4 kg were employed, 
both for supplying the platelets and the PAF.  Blood for platelet preparation was not removed at 
intervals of less than 1 mo. 
Immunization.  Horse radish peroxidase  (type II,  Sigma Chemical  Co.,  St.  Louis,  Mo.)  was 
employed as antigen. The initial injection comprised 1.0 mg in saline subcutaneously into 2.5 kg 
rabbits. Thereafter, animals were reimmunized with 5 mg/injection at variable intervals (1-6 mo). 
The rabbits were bled for PAF production 10 days after each immunization. 
Preparation of Platelets.  Rabbit platelets were prepared as previously described  (18).  Blood 
was taken into acid citrate dextrose (ACD) (as for PAF production) and centrifuged at 550 g  (1,600 
rpm) for 20 min. The entire preparation procedure was carried out at room temperature and with 
plastic containers and pipettes.  Platelets from different rabbits were usually pooled, a procedure 
that in our hands has not led to any behavioural differences from platelets prepared from a single 
animal. The platelet-rich plasma was removed and incubated at 37°C with 0.6 ~Ci [:~H]serotenin, 
binoxalate (4.3 Ci/mmol),  New  England Nuclear,  Boston,  Mass.  for 15 min. The platelets were 
sedimented at 1,800 g  (3,000 rpm) for 15 min and washed first in Tyrode's gelatin without Ca + + 
and with  EGTA  (see  below)  and then  in Tyrode's gelatin without  Ca++.  The  platelets  were 
resuspended in the latter buffer and diluted to 4 × 10  "~ or 2.5 x  10" depending on the experiments to 
be performed. The concentration was determined from a standard curve of absorbance at 530 nm. 
The  preparation  procedure  is  essentially  that of Ardlie  et  al.  (19)  and preserves  the  platelet 
Mg+ +. Such platelets are readily aggregated by adenosine diphosphate (ADP) in #M concentra- 
tions and are predominantly discoid in shape.  These characters are both indicative of relative 
normality. The platelets were maintained at room temperature and used within 3-4 h of prepara- 
tion.  While their reactivity to  ADP declined somewhat over this time,  that to  PAF remained 
unaltered. 
Buffers.  (a)  Tyrode's  solution:  NaC1,  8  g/liter;  KC1,  0.195  g/liter;  NaHCO.~,  1.02  g/liter; 
MgC126H~O,  0.213  g/liter;  CaCl2  (anhydrous),  0.145  g/liter; glucose,  1 g/liter; pH  7.2.  (b) Tris- 
Tyrode's solution:  same  as  above with  0.01  M  tris-(hydroxymethyl) amino-methane instead of 
NaHCO:~.  (c) Tyrode's gelatin: same as (a), with 0.25% gelatin. (d) Tyrode's bovine serum albumin 
(BSA): same as  (a) with 0.25% BSA.  (e) Tyrode's gelatin without Ca+ +; basic Tyrode's gelatin 
with calcium omitted and a pH of 6.5.  (f) Tyrode's gelatin without Ca+ +  and with EGTA; same as 
(e) but with 0.1 mM ethylene glycol tetraacetate. (g) Tris-Tyrode's without Ca+ +  or Mg+ +. 
Preparation of PAF.  Blood was obtained from the central ear artery into 1/6 vol of ACD (20). 
The procedure thereafter was similar to that previously described (4, 7). The blood was sedimented 
at 550 g  (1,600 rpm) in an International PR6 centrifuge (International Equipment Co.,  Boston, 
Mass.) for 20 min at room temperature.  The platelet-rich plasma was removed.  The buffy coat 
layer on  top of the erythrocytes  was  harvested  with  a  siliconized  (Siliclad,  Clay-Adams,  Inc. 
Parsippany, N.  Y.) Pasteur pipette with tip bent at right angles.  Once rabbits had been estab- 
lished as producing PAF (producing IgE antibody), buffy coat cells from all the positive animals 
were pooled. Erythrocytes, platelets, and lymphocytes were now the predominant contaminants of 
the basophil preparation. Addition of equal volumes of 2.5% gelatin in isotonic phosphate-buffered 
saline (PBS) was followed by incubation at 37°C for 30 min in an incubator to sediment most of the PETER  M.  HENSON  939 
erythrocytes. The supernatant cell suspension was removed, centrifuged at 500g (1,500 rpm) for 15 
min at room temperature.  The cell pellet was  resuspended in a  small volume of Tris-buffered 
Tyrode's solution with no Ca+ +  or Mg+ +  and with EGTA (see below). Remaining erythrocytes 
were removed by hypotonic lysis. For each 2 ml of cell suspension, 6 ml of distilled water was added 
and after 30 s, 2 ml of 3.5% saline was used to restore isotonicity. Platelets were removed by 4-5 
washes,  8  min  at  180 g  (900  rpm)  in 50-ml  plastic tubes using Tris-buffered Tyrode's solution 
without Ca+ + or Mg+ +. Cells were resuspended to 1 x  107 leukocytes in Tris-Tyrode's with 0.25% 
BSA  and  were  contaminated  with  less  than  10  ~ per  ml  platelets.  The  cell  concentration  is 
important since if it is higher, the PAF apparently binds to the other cells present and the yield is 
lowered.  Basophils comprise  from  3  to  6%  of the  final leukocyte  preparation.  The albumin is 
essential and provides a carrier for the PAF that binds to it. Antigen (50 tLg peroxidase for each 107 
cells) was added and incubated for 20 min at 37°C.  The cells were removed (500g, 1,500 rpm for 10 
min), and the supernatant fluid containing PAF-albumin was tested (see below), dialyzed against 
PBS or Tris-buffered saline overnight at 4°C,  and frozen in aliquots at -70°C. 
Extraction of  PAF.  PAF was extracted from the albumin by the method described by Benven- 
iste (8). Ethanol was added to 80%, and after 15 min at room temperature the precipitated protein 
was removed by centrifugation. The extracted PAF was evaporated to dryness at room tempera- 
ture  and redissolved  immediately in  either ethanol or Tyrode's gelatin solution.  In the  latter 
instance the PAF was used immediately as it loses activity in aqueous solution (4,  8). 
Platelet Stimuli.  Antiplatelet antibody was prepared  and absorbed as previously described 
(18),  except that a goat rather than a  sheep was immunized. A gamma globulin preparation (18) 
was used. Zymosan-C3 (ZC3) was prepared by incubating 17 mg zymosan (ICN Pharmaceuticals, 
Inc.,  Cleveland,  Ohio)  per ml  one-third fresh  rabbit serum  in Tyrode's for 20 min  at  30°C  as 
previously described  (21).  The ZC3 was washed extensively and frozen in aliquots at  -70°C.  A 
preparation of zymosan incubated in serum with 10 mM EDTA  (which prevents the binding of 
complement) was employed as control. Thrombin (bovine, Parke Davis & Co., Detroit, Mich.) was 
diluted in Tyrode's gelatin. Epinephrine (Parke Davis & Co.) was also diluted in Tyrode's gelatin, 
but only immediately before use. Collagen was prepared by homogenization and then sonication of 
bovine tendon collagen (Sigma Chemical Co.) in saline. Unlabeled serotonin (serotonin creatinine 
sulfate) was obtained from Sigma Chemical Co. 
Platelet Secretion.  The standard reaction mixture contained 0.1 ml 2.5 x  10  ~ platelets, varying 
amounts of PAF, and Tyrode's gelatin in 1 ml. The final concentration of platelets was thus 2.5 × 
108/ml. The platelets were generally added last, unless otherwise indicated. The reactions were 
performed in 12 x  75-mm polystyrene tubes (Lancer, Sherwood Medical Industries, Inc., St. Louis, 
Mo.) at 37°C for 10 min. Tubes were then cooled to 4°C in ice and centrifuged in the cold at 1800g, 
3,000 rpm for 15 min. An aliquot (0.1 ml) of the supernate was removed, and the radioactivity was 
counted in a  mixture of equal parts toluene and Aquasol  (New England Nuclear) in a  Beckman 
liquid scintillation counter (Beckman Instruments, Fullerton, Calif.). The secreted [3H]serotenin 
was usually expressed as a  percentage of the total taken up by the platelets, determined by lysis 
with  Triton  x  100.  Generally,  0.1  ml  of 2.5  ×  108/ml  platelets  contained  18-25  ×  103  cpm. 
Background  secretion  from  platelets  incubated  without  stimulus  was  usually  subtracted  and 
seldom  exceeded  2%  of the  total  (see  results  section).  Reactions  were  generally performed  in 
duplicate. Kinetic experiments were performed by incubating 0.5 ml, 4 x  109/ml platelets with 0.5 
ml of PAF dilution and 1.0 ml Tyrode's gelatin (i.e., 1 x  10"/ml final concentration of platelets). At 
intervals 50-ttl aliquots were removed and added to 0.45 ml of ice-cold Tyrode's gelatin containing 
5  mM EGTA to completely and instantly stop the secretion.  Tubes  were then centrifuged and 
supernates counted. 
Results 
The Effect of PAF Concentration on Secretion.  Increasing amounts of PAF 
complexed to albumin (4) were incubated with platelets (2.5 x  10S/ml) for 10 min 
and the release of [3H]serotonin was ascertained (Fig. 1). It should be noted that 
the use of [3H]serotonin as a marker for endogenous serotonin (and histamine, 7 
and 18) secretion has recently been validated  (22).  Since PAF has not yet been 
fully  characterized,  its  absolute  concentration  is  unknown.  The  data  are  ex- 940  INDUCED  BY  PAF  PLATELET  SECRETION 
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Fro.  1.  Dose  response of PAF-induced secretion of [:~H]serotonin  from platelets.  Each 
curve represents the mean release from duplicate incubations (10 rain at 37°C in 1 ml) of 
different preparations of 2.5  ×  108/ml platelets.  Control  (negative) PAF represents the 
supernatant fluid from sensitized basophils incubated with an unrelated antigen. Similar 
negative controls were seen with supernates from unsensitized basophils incubated with 
peroxidase. EGTA blocked the secretion. 
pressed here as microliters of standard preparations  (the supernatant from 1 x 
107 sensitized  leukocytes/ml,  dialyzed,  and  containing  0.25%  BSA).  The  data 
depicted  in  Fig.  1  results  from  five  different  platelet  preparations  and  two 
different PAF preparations.  The results  (when expressed as percent secretion) 
are remarkably similar.  The amount of serotonin released increases to a maxi- 
mum value of between 45 and 60%, remains at that value as the PAF concentra- 
tion increases, and then at high levels of PAF the amount of secretion declines. 
By concentrating the PAF-albumin complexes (ultrafiltration),  PAF concentra- 
tions can be achieved which result in almost complete suppression  of release 
(not shown). The peculiar nature of this dose response will be discussed below. 
Control  preparations,  i.e.  supernate  from  sensitized  leukocytes  (basophils) 
incubated with no antigen or with an unrelated antigen (e.g., BSA) or nonsensi- 
tized leukocytes reacted with peroxidase, gave no serotonin secretion (Fig. 1 and 
reference 7).  Controls to confirm the secretory nature  of the serotonin release 
have  been  reported  earlier  (7)  and  include  demonstration  of the  absence  of 
release of cytoplasmic constituents such as lactic dehydrogenase, amino acids, or 
K +. The complete inhibition of secretion with 5 mM EGTA is also shown, as this 
agent will be used to terminate  the secretion in kinetic experiments. 
Secretion Kinetics.  Platelets were incubated with varying concentrations of 
PAF, and aliquots were removed at intervals into cold EGTA-containing buffer. 
Fig.  2  depicts  the  secretion  rates.  A  number  of points  emerged  from  these 
experiments:  (a)  The  secretion  is  extremely rapid,  being  generally  complete 
within 1 min. This contrasts with other stimuli for rabbit platelet secretion (18, 
21). Thus concentrations of PAF, thrombin, antiplatelet antibody, and collagen, 
which stimulate 50% secretion, yield initial secretion rates of 85, 28, 20, and 10% 
per min,  respectively. However, high concentrations of thrombin  (giving 100% PETER  M.  HENSON 
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Fro.  2.  Kinetics of secretion of [3H]serotonin from platelets with different concentrations 
of PAF.  PAF was incubated with  1  ×  109/ml  platelets, and aliquots were removed and 
diluted into ice-cold EGTA-containing buffer to halt the reaction. 
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Fxc.  3.  The relationship of secretion rates to PAF concentration. Initial rates of secretion 
induced by PAF,  or for comparison by thrombin, are expressed as percent released per 
minute. Concentrations of thrombin are expressed in mU (0.001 U). The incubation condi- 
tions were identical with those of Fig. 2. 
secretion) result in maximum secretion rates three times greater than those of 
PAF (Fig. 3).  (b) There is a distinct lag period before secretion starts, but this 
period is very short, about 0.1 min. Because of the expanded scale, this is more 
clearly shown in Fig. 4. Surprisingly, this lag is approximately the same over a 
wide range of PAF concentrations. (c) The rate and extent of secretion vary as 
the PAF concentration. Fig. 3 depicts this relationship, showing that the log of 
the initial secretion rate is proportional to PAF concentration over a considera- 
ble range, but approaches a maximum with high concentrations. 
Platelet Concentration.  To determine the effect ofplatelet concentration on 
PAF-induced secretion, the kinetic experiments were repeated, but with vary- 
ing concentrations of platelets. It may be seen (Fig. 4 and 5) that secretion (rate 
and extent) was optimal at rather low platelet concentrations (2.5  ×  10S/ml), 
diminishing as the concentration increased or decreased. This contrasts with 942  PLATELET  SECRETION  INDUCED  BY  PAF 
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Fro.  4.  Kinetics of secretion induced by PAF on different concentrations ofplatelets. PAF 
(100  ~l/ml) was incubated with platelets at the indicated concentrations, and the reaction 
was terminated as described in Fig. 2, 
secretion  induced  by thrombin  that  increases  in  rate  with  increased  platelet 
concentration over all concentration tested (Fig. 5). Other stimuli  (antiplatelet 
antibody  and  ZC3)  also  require  much  higher  concentration  of platelets  for 
optimal  secretion  (data not shown).  Accordingly,  experiments  were generally 
performed at a  concentration of 2.5  ×  108 platelets/ml. 
Temperatures.  The effect of temperature on the secretion induced by PAF is 
depicted in Fig. 6. Of interest,  it may be noted that the extent of secretion was 
also markedly temperature dependent, indicating some mechanism for shutting 
off the secretory process (see below). This has been expressed as either initial 
rate  of secretion  or  as  extent  of  secretion  (here  as  counts  per  minute  of 
[3H]serotonin  released)  in  an  Arrhenius  plot  in  Fig.  7.  It  may  be seen  that 
secretion was maximal at 37°C and that a 'break' was observed in the Arrhenius 
plot at about 20°C.  Subsequently, experiments were performed at 37°C. 
pH.  The  effect  of varying  pH  on  platelet  secretion  is  shown  in  Fig.  8. 
Optimal secretion was observed at about pH 7.7, and release was inhibited at pH 
6.5.  Higher  pH's induced  spontaneous  release  of serotonin,  and  backgrounds 
started increasing at pH 7.5.  Consequently, experiments were performed at pH 
7.4. 
Are all the platelets affected by PAF?  The inability to obtain more than 50- 
60%  secretion  of serotonin  with  PAF  raises  the  possibility  that  only  50%  of 
platelets respond to the stimulus. Alternatively, all the platelets respond, but by 
secreting only 50% of their contained vasoactive amines.  This is an important 
question.  Experiments  were  performed  to  determine  whether  the  serotonin 
remaining after PAF-induced secretion could be secreted in response to another 
stimulus,  in  this  case,  ZC3.  The  data  in  Fig.  9  indicate  that  this  residual 
serotonin is indeed releasable. However, this could still imply two populations of 
platelets. 
The Effect of Ethanol-Extracted  PAF.  In Fig.  10 the dose response of PAF- 
albumin and of PAF extracted from this with ethanol is compared and provides 
an answer to the question of different platelet populations.  It may be seen that 
the extracted PAF induces secretion of up to 90% of the serotonin.  This clearly PETER  M.  HENSON  943 
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FIG.  5.  The relationship of rate and extent of secretion to concentration  of platelets.  The 
conditions employed were those described in Fig.  2. 
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FiG.  6.  Kinetics  of  secretion induced by PAF at different  temperatures. Platelets (1 ×  10"/ 
ml)  were  incubated  with  PAF  (100  pl/ml)  at  different  temperatures,  and  aliquots  were 
diluted into cold EGTA-containing  Tyrode's  solution  to halt the secretion. 
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rules out the possibility of two populations of platelets, demonstrates the like- 
lihood that all the platelets interact with the PAF, and suggests some control- 
ling process to limit the extent of  the secretion. It also shows that extracted PAF 
behaves in this regard differently  from albumin-bound PAF. However, secretion 
rates, desensitization, and the other parameters discussed are similar for both 
forms of PAF. 
Specific Desensitization of  Platelets by PAF.  The data in Fig. 9 showed that 
platelets limited to 50% release with PAF were still capable of releasing sero- 
tonin with ZC3. This suggested the possibility that the platelets were desensi- 
tized to PAF but not to ZC3. To show this more clearly, platelets were incubated 
for 30 rain at 37°C with PAF in the presence of 5 mM EGTA (i.e., in the absence 
of calcium)  to  inhibit  secretion  but  still  allow  interaction  of PAF  and  the 
induction of  desensitization. Control platelets were incubated with EGTA alone. 
The platelets were then washed and tested for their ability to secrete serotonin 
in response to the different stimuli depicted in Table  I.  It may be  seen that 944  PLATELET  SECRETION  INDUCED  BY  PAF 
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FIG.  7.  Arrhenius  plot  of  rate  or  extent  of  secretion  (expressed  as  counts  per  minute 
released per minute or counts per minute released).  The experimental  conditions were those 
described  in Fig.  6. 
platelets were specifically desensitized to PAF if they had been pretreated with 
PAF, but still reacted perfectly well to all the other stimuli. In fact an enhanced 
response  to the  other stimuli  was  observed in  platelets  pretreated  with  PAF 
compared with those pretreated with EGTA alone. This enhancement is proba- 
bly due to the lowering of the intracellular cyclic AMP by the PAF (even in the 
absence of Ca+ +) which enhances the secretory response (23). That this is the 
likely  explanation  is suggested  by the effect  of theophylline,  which  increases 
cyclic  AMP by inhibiting phosphodiesterase,  and which reduced the enhance- 
ment observed by pretreatment  with  PAF  (Table II).  It may also be observed 
that serotonin, which probably induces [3H]serotonin release by some exchange 
process,  not modulated by cyclic  AMP  (Henson unpublished observations) did 
not exhibit the enhancement phenomenon. 
Rate of Desensitization.  The  desensitization  of platelets  to PAF might ex- 
plain the limitation of the dose response  (Fig.  1) to a  maximum of about 50% 
secretion.  Thus,  as the desensitization  increased,  the  secretion would be shut 
off. Fig. 11 depicts an example of an experiment to measure the rate of desensiti- 
zation.  Platelets  were  incubated  with  PAF  and EGTA for varying times  and 
then diluted in Tyrode's gelatin to noninhibitory concentrations of EGTA and to 
nonstimulating  concentrations  of PAF.  Tubes  were  then  incubated  with  or 
without  additional  PAF  to  determine  the  degree  of desensitization.  Control 
platelets  (no PAF in the first incubation) exhibited no desensitization,  whereas 
platelets  pretreated  with  PAF  showed  increasing  desensitization  starting  at 
about 1 min which, interestingly,  is the point at which the secretion rate starts 
diminishing  (also shown in Fig.  11). PETER  M o HENSON 
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FIG.  8.  Secretion induced by PAF at different pH's. Tyrode's solution was buffered with 
Tris and the platelets (2.5  ×  108/ml) incubated with PAF for 10 min at 37°C. 
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FIG.  9.  The effect of ZC3 on platelets stimulated maximally with PAF. The ZC3  (50 mg/ 
ml) was added simultaneously with the PAF and incubated with the platelets (2.5 x  10X/ml) 
in 1 ml for 15 rain at 37°C. 
Desensitization with Ethanol-Extracted PAF.  The PAF extracted from albu- 
min with ethanol  behaves in most respects like albumin-bound  PAF.  Experi- 
ments depicted (data not shown) that platelets can be desensitized to extracted 
PAF  if incubated  with  it  in  nonreleasing  conditions  (i.e.,  in  the  presence  of 
EGTA).  Moreover,  platelets  made  unresponsive  to  albumin-bound  PAF  re- 
mained unresponsive to the extracted material. 
Discussion 
The low molecular weight factor, PAF, which is released from IgE-sensitized 
basophils  upon  reaction  with  antigen  has  been  shown  to  be  a  very  potent 
stimulus  for  platelet  secretion.  It  is  our  hypothesis  (17)  that  secretion  from 
mediator-containing  cells such as platelets is an essentially similar process to 
secretion from a  wide variety of cell types. Most of the characteristics  of PAF- 
induced secretion, as described herein,  do not dispute this point.  Nevertheless, 
other factors, particularly the peculiar dose response relationship,  appear to be 
unique to this particular platelet stimulus. 946  PLATELET  SECRETION  INDUCED  BY  PAF 
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TABLE  I 
Desensitization of Platelets to PAF 
Stimulus 
Percent release serotonin ±  SEM 
Platelets pre-  Platelets pre- 
treated with  treated with 
EGTA  PAF and EGTA 
PAF (20 ~tl)  43.1  ±  1.4  9.0 +- 1.5 
ZC3 (3 rag)  60.8 ±  4.0  77.6 -+ 2.6 
A-P Ab (100 ~g immunoglobulin)  60.2  _+  1.5  74.0 _+ 2.1 
Collagen  23.7  _+ 3.1  43.7 _+ 5.3 
Thrombin (0.016 U)  78.4 +_ 2.5  92.3  ± 4.7 
Epinephrine (4 x  10 -4 M)  18.9 +_ 4.3  31.0 ±  5.5 
Serotonin (2  x  10 -~ M)  38.3  +- 2.4  35.3  -+ 2.1 
None  2.8 _  0.5  6.3 -+ 1.2 
Platelets (2.5 x 10") were pretreated for 30 min at 37°C with 5 mM EGTA 
in the presence or absence of 200 ~1 PAF. They were then washed, and 
aliquots (2.5 × 10  ~) were incubated with the different stimuli for 15 min 
at 37°C. 
The release of vasoactive amines from rabbit platelets by PAF is noncytotoxic 
(7) and was completely inhibited by calcium deprival. It is a  true example  of a 
secretory process  (17)  and requires platelet energy  (7),  and as described in the 
accompanying paper (23) is modulated  by cyclic nucleotides and requires micro- 
tubule  function  and an  activatable  serine  protease.  This  contrasts  with  the 
suggestion  of Siraganian  and  Osler  (24)  that  the  effect  of PAF  is  cytolytic. 
However,  their conclusion was based on release of '~lCr from chromium-labeled 
platelets, which may not be an adequate  indication of cytotoxicity. The absence 
of  release  of  K ÷  (actually  86Rb  was  used)  or  cytoplasmic  enzymes,  and  the 
absence of morphologic evidence of lysis seems to refute this point (7). Moreover, 
as seen in Fig.  11, prolonged incubation of platelets after induction of secretion 
resulted in some uptake  of the released serotonin,  surely a  contraindication  of 
cytotoxicity. 
The  inability of PAF  when  bound  to albumin  to stimulate  more than  about 
50% secretion of vasoactive amines may be explained by the concurrent desensi- 
tization induced in platelets by the PAF. The rate of induction of desensitization PETER  M.  HENSON 
TABLE II 
Inhibitory Effect of Theophylline on the Enhancement of Secretion 
Seen in PAF-Pretreated and Desensitized Platelets 
947 
Percent  release  sero- 
tonin  Percent en- 
hancement  Pretreatment (stimuli in  Platelets  Platelets  due  to  PAF  second incubation)  pretreated 
pretreated  with  pretreat- 
with  ment  EGTA and  EGTA*  PAF 
Control pretreatment 
PAF  44.5  10.5 
ZC3  24.1  34.0  41 
Anti-PAb  66.7  76.0  14 
-  0.3  0.3 
Theophylline  (10  -'~ M) present dur- 
ing pretreatment 
PAF  33.1  9.5 
ZC3  21.5  25.1  13 
Anti-PAb  53.5  54.0  1 
-  0.7  0.4 
* Pretreatment conditions were the same as those in Table I. 
is certainly less than that  of secretion,  but before long becomes predominant, 
and secretion ceases. As the PAF concentration is increased,  the secretion rate 
may also increase. However, a finite time is necessary for secretion to occur, and 
at  a  given point  the  desensitization  is  rapid  or early  enough  that  no further 
increment of secretion  is seen.  The desensitization  results  from interaction  of 
PAF with the cell, a  process that is also presumably related to PAF concentra- 
tion. The relationship to each other of rates of 'activation', 'decay' and 'desensiti- 
zation' are under investigation and will be reported elsewhere  2. It is of interest 
that  mast cells,  whose  secretory properties  are  very similar to platelets,  also 
exhibit a  limitation of secretion by desensitization  (25)  which may in part be a 
general phenomenon (17). A  cobra venom activating agent acts on mast cells in 
a  manner similar to that of PAF on platelets  (26) to yield a  maximum  of only 
about  50%  release  of serotonin.  This  again  appears  to  be  due  to  the  rapid 
desensitization. 2 
Another  hypothesis  to  account  for  the  maximum  secretion  of about  50%, 
namely that  a  unique  population  of platelets  is  involved,  appears unfounded. 
The ability of extracted PAF to induce more than  90%  secretion demonstrates 
that most of the platelets can respond. The unique effect of albumin-bound PAF 
may result from the density of PAF on the albumin, conferring a greater ability 
to induce desensitization,  and this is under investigation. It should be noted that 
the  binding  to  albumin  is  rapid,  and  the  effects of PAF  in  vivo may involve 
totally or partially protein-bound material. Moreover, the extracted PAF is very 
2 Morrison, D. C., and P. M. Henson. Regulation  of the rate and extent of secretion from mast 
cells and platelets by the nature of the stimulus-cell  interaction. Submitted for publication. 948  PLATELET  SECRETION  INDUCED  BY  PAF 
First Incubation  Second Incubation 
1.Platelets  + PAF  None 
2.Platellts + PAF + EGTA  ]  (  +Ca  ++  +PAF  ~--o 
3.Platelets + EGTA  cifute  +Ca  ++  +PAF 
2  3  4  5  10 
First  Incubation  (Minutes I 
FIG. 11.  Rate  of desensitization ofplatelets to PAF. (a) Platelets (108/ml) were incubated 
with PAF (50/zl/ml) and the time-course  of secretion determined as in Fig. 2. (b)  Platelets 
(10"/ral) were incubated with PAF (50 /~l/ml) in the presence of 5 mM EGTA. At intervals 
aliquots were diluted one-tenth in Tyrode's gelatin containing Ca  ++ to which PAF (50 /zl/ 
ml) has been added and incubated for a further 10 min. (c)  Platelets were incubated with 
EGTA, and at intervals aliquots were diluted in Tyrode's  solution with PAF and incubated 
for a further 10 min. 
unstable, and considerable activity is usually lost during the process. Despite 
this difference between the extracted and albumin-bound PAF, in other respects 
they appear identical. Thus, platelets can be desensitized by both forms of PAF 
(under conditions of calcium deprivation) and are thus unresponsive to both the 
bound and the extracted materials. Other evidence against unique populations 
of cells comes from data showing that in platelets exhibiting maximum release 
with PAF of 50%, this can be increased to over 70% in the presence of 1 x  10  -.~ M 
epinephrine  (acting as  an alpha  adrenergic agent),  again showing that more 
than  50%  of the platelets can respond  (see reference 23).  The presence of an 
inhibitor, as well as an activator, in the PAF preparation might also explain the 
data,  although the  argument expressed above against  unique populations of 
platelets would also serve to diminish the likelihood of this explanation. 
The  data  also  provides  evidence  to  answer  another  important  question, 
namely when 50% of the serotonin is released, do all the platelets respond by 
50% of their capacity or do 50% respond fully? Inasmuch as total desensitization 
can be achieved with doses of PAF which induce only 50% secretion and yet 
there are not unique populations of platelets responsive to PAF, it appears that 
all  the platelets respond to PAF.  This is  important since it implies that the 
platelets can be visualized and studied as a pure population of  relatively uniform 
cells. 
The rate of secretion induced by PAF is dependent upon the concentration of 
PAF and also,  as expected, upon the concentration of platelets.  Surprisingly, 
however, compared with other stimuli such as thrombin, antiplatelet antibody, 
or C3,  the optimal platelet concentration (for rate and extent of secretion) was 
low, about 2.5  ×  10S/ml. It is perhaps significant, however, that this approxi- 
mates the blood concentration of platelets in the rabbit. The mode of interaction PETER  M.  HENSON  949 
of PAF with the platelets is not known. Preliminary data with BSA-PAF bound 
to Sepharose 4B suggests that platelet activation with insoluble PAF is possible, 
indicating that  PAF probably, as do other platelet stimuli,  acts at the surface 
membrane. The observation that increased platelet concentrations (above 2.5 × 
10S/ml) resulted in a decreased initial rate of secretion (in complete contrast to 
the  enzyme  thrombin),  provides  a  number  of clues  about  the  PAF-platelet 
interaction.  It would certainly suggest that the PAF did not dissociate from one 
platelet and then  act on another.  It thus implies a  high binding afffmity com- 
pared with the other stimuli  (whose optimal cell concentration was above 5  x 
109/ml) or an inactivation of the PAF once it has bound. Since the initial rate of 
secretion decreases with increased platelet concentration, this suggests that the 
rate  of binding  (expected to increase  with  increase  of either platelet  or PAF 
concentrations) is not the rate-limiting  factor in the secretion. 
The temperature and pH optima for the PAF-induced secretory process are as 
expected, those of normal physiologic conditions. Interestingly,  when the tem- 
perature  dependence is plotted as an  Arrhenius  plot,  both rate  and  extent of 
secretion show a  sharp break at about 20°C. This is similar to the temperature 
dependence  curves  described for the  effect of polymyxin B  (27)  and  of cobra 
venom activator  (Morrison,  D.  C.,  personal  communication)  on mast cells as 
well as for other stimuli on rabbit platelets. This serves to further the ideas of 
similarities  between secretion from different cells.  It has been suggested that 
this ~break' corresponds to a  phase change in the membrane lipids resulting in 
decreased  receptor  mobility  (27)  and  has  been  used  to  argue  for the  role  of 
receptor aggregation in cell stimulation.  While this is an attractive hypothesis 
and indeed, receptor aggregation may well be a key point in cell activation, the 
temperature  data is certainly open to other interpretations.  All it really indi- 
cates is that from 37°C  to 20°C,  one temperature-sensitive  step in the compli- 
cated secretion process is rate  limiting  and that  below 20°C another predomi- 
nates.  Platelets undergo shape changes at 4°C  (28) which if they also occur in 
part at higher temperature  (15°C-20°C) may contribute to the secretion data. It 
is of interest with regard to PAF that the extent of secretion is also temperature 
sensitive. This implies that if indeed it is the desensitization that switches off 
the secretion, the desensitization process is not the temperature-sensitive,  rate- 
limiting step. 
The  stimulus  specificity of the  desensitization  was  demonstrated,  since  all 
other stimuli examined induced greater secretion from PAF-desensitized than 
from control platelets. An early, stimulus-specific step in the secretion (activa- 
tion) process is implied. Recent evidence (29, 30) has indicated that this may be a 
specific stimulus-activated  platelet  serine  protease  which  is  required  for cell 
activation.  The  increased  release seen with the other stimuli  seems to result 
from the effect of PAF in reducing the levels of intracellular cyclic AMP in the 
platelets (23). This was shown by diminution of the increase in platelets treated 
with theophylline, an agent that increases cyclic AMP by inhibiting phosphodi- 
esterase. 
Since specific desensitization does result from interaction of PAF with plate- 
lets, this may also occur in vivo. It could then act as a  physiologic controlling 
influence.  It  might  also  be  detected  experimentally  and  used  to  determine 950  PLATELET  SECRETION  INDUCED  BY  PAF 
whether or not in vivo platelet secretion or temporary platelet sequestration (as 
in IgE anaphylactic shock,  15) had resulted from release of PAF.  Preliminary 
observations with Dr. Neal Pinckard of  the University of Arizona have indicated 
that PAF-desensitized platelets can indeed be detected in rabbits undergoing 
IgE  anaphylaxis.  This would  demonstrate  in  IgE-mediated pathophysiologic 
events in the  animal the  involvement of the phenomena described herein in 
vitro. 
Summary 
The  secretion  of vasoactive  amines  from  rabbit  platelets  induced  by  the 
platelet-activating factor (PAF) derived from IgE-sensitized rabbit basophils, 
was examined. The secretion required calcium has previously been shown to be 
noncytotoxic and  was  optimal  in  both  rate  and  extent  at  37°C and  pH  7.2. 
Different temperature-sensitive steps were rate limiting for secretion above or 
below 20°C. The rate of secretion was dependent upon the concentration of PAF 
and also of platelets. Maximal rates were observed with relatively low concen- 
trations  of platelets  (2,5  x  10S/ml),  sharply  contrasting  with  other platelet 
stimuli such as  C3  or thrombin. The extent of secretion was dependent upon 
PAF concentration until a maximum of 50 or 60% of the serotonin was released 
and  then declined with increasing amounts  of PAF.  This was  interpreted to 
result from the platelets becoming desensitized to the PAF, a process that shuts 
off the secretion. Such a desensitization was demonstrated and was shown to be 
stimulus  specific,  i.e.,  other  stimuli  could  still  induce  secretion from  PAF- 
desensitized platelets. PAF extracted with ethanol from the albumin to which it 
is usually bound during preparation, exhibited similar characteristics, except 
that secretion of up to 90% of  the serotonin was induced. The extracted PAF thus 
seemed less able to induce the desensitization. Its use did provide important 
evidence that populations of rabbit platelets are relatively homogenous in their 
ability to respond to PAF. 
The author is indebted to David Morrison for invaluable discussion, to Zenaida Oades, Rick 
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